Methyl iodide → HCID 178430231, compound
Reaction equation
[CH3:1][C:2]1[C:3]2[S:10][C:9]([C:11]3[N:15]4[N:16]=[C:17]([NH:20][C@H:21]5[CH2:26][CH2:25][C@H:24]([OH:27])[CH2:23][CH2:22]5)[CH:18]=[CH:19][C:14]4=[N:13][CH:12]=3)=[CH:8][C:4]=2[CH:5]=[N:6][CH:7]=1.[H-].[Na+].[CH3:30]I>CN(C=O)C>[CH3:30][N:20]([C@H:21]1[CH2:26][CH2:25][C@H:24]([OH:27])[CH2:23][CH2:22]1)[C:17]1[CH:18]=[CH:19][C:14]2[N:15]([C:11]([C:9]3[S:10][C:3]4[C:2]([CH3:1])=[CH:7][N:6]=[CH:5][C:4]=4[CH:8]=3)=[CH:12][N:13]=2)[N:16]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of trans-4-(3-(7-methylthieno[3,2-c]pyridin-2-yl)imidazo[1,2-b]pyridazin-6-ylamino)cyclohexanol (37 mg, 0.0975 mmol, 1.0 equiv) in DMF (2.00 mL) was added sodium hydride (20 mg, 0.488 mmol, 5.0 equiv) and methyl iodide (68 mg, 0.488 mmol, 5.0 equiv). After 2 h, the reaction mixture was quenched with water and extracted with ethyl acetate. Purification by column chromatography gave 20 mg (50%) of N-((1r,4r)-4-methoxycyclohexyl)-N-methyl-3-(7-methylthieno[3,2-c]pyridin-2-yl)imidazo[1,2-b]pyridazin-6-amine as the less polar product and 10 mg (25%) of trans-4-(N-methyl-N-(3-(7-methylthieno[3,2-c]pyridin-2-yl)imidazo[1,2-b]pyridazin-6-yl)amino)cyclohexanol as the more polar product.
Workup
- customthe reaction mixture was quenched with water
- extractionextracted with ethyl acetate
- customPurification by column chromatography
Sources & evidence
- ORD record
- ord-b6927ab0505d42278d82dfb53fcfa1cd
- Source dataset
- uspto-grants-2016_06
- Patent number
- US09370515B2
Reaction notes
Loading…